Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-00489791 in Primary and Secondary Raynaud's Phenomenon
NCT01090492Phase 2Completed
- Sponsor
- Pfizer
- Start
- Aug 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of PF-00489791 in Raynaud's phenomenon (RP), sponsored by Pfizer. Started Aug 2010; status: completed.
02
Drugs
PF-00489791
03
Conditions
Raynaud's phenomenon (RP)
Beyond the preview
Go deeper on NCT01090492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01090492.